ABcann Medicinals Inc (ABCN)

[NetworkNewsWire]

ABCN Scales Up in Preparation for Canada’s Impending 2018 Recreational Cannabis Legalization

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date. The company’s high-tech indoor growing environment—with every facet of the growing, curing and harvesting process controlled and monitored by computer—yields a high-quality product that is clean, steady and repeatable—something the company can effectively leverage should recreational cannabis legalization go through in 2018. An article discussing this reads: “Focused on scaling its operations and distinguishing itself through its proprietary organic and pesticide-free growing technology, ABcann has been making strategic strides in recent months. The company recently announced the receipt of $11.9 million in proceeds from the exercise of warrants. Combined with a previous investment from Cannabis Wheaton Income Corp., this brought ABcann’s cash position to about $45 million, and, in the coming months, the company intends to deploy capital toward expanding its existing Vanluven facility and in developing and constructing its new Kimmett facility. The company will further pursue international expansion plans.”

To view the full article, visit http://nnw.fm/PpcL8

About ABcann Global Corporation

ABcann was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product. For more information, visit www.ABcannGlobal.com